14 January 2008
CHINA EASTSEA BUSINESS SOFTWARE LIMITED
("CHINA EASTSEA" OR "THE GROUP")
DELISTING AT PLUS MARKET
China Eastsea is pleased to announce that on Tuesday 8 January it submitted a
Schedule 1 to AIM Regulation in connection with the proposed admission of China
Eastsea's ordinary shares of 5p each ("Ordinary Shares") to trading on AIM
("Admission"). It is expected that Admission will become effective on 24
January 2008 and that subject to Admission occurring the trading of the
Ordinary Shares on PLUS Markets will be cancelled with effect from this date.
It is expected that an AIM Admission Document in connection with the proposed
Admission will be published on 17 January 2008. Copies will be available free
of charge, during normal business hours, from the offices of Evolution
Securities China Limited, 29-30 Cornhill, London, EC3C 3NF.
The directors of China Eastsea Business Software Limited accept responsibility
for this announcement.
For further information please visit www.sinobpo.com, or contact:
Angie Chen
Company Secretary
Tel: +86 10 62988850
David Tsui
Financial Director/CFO
Tel: +86 13816685470
China Eastsea Business Software Limited
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.